Loading

Sensus Healthcare to Host First Quarter 2017 Financial Results and Business Update Conference Call on May 4, 2017

Sensus Healthcare to Host First Quarter 2017 Financial Results and Business Update Conference Call on May 4, 2017

BOCA RATON, Fla., April 27, 2017,/PRNewswire/ — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), announced today that management will hold a conference call beginning at 4:30 p.m. Eastern Time on Thursday, May 4, 2017, to discuss the financial results for the first quarter of 2017. In addition, management will provide a business update and a discussion on recent and upcoming milestones.

To access the conference call, the dial-in numbers are 1-877-870-4263 (U.S. Toll-Free), 1-412-317-0790 (International) and 1-855-669-9657 (Canada Toll-Free). Please ask the operator to be connected to the Sensus Healthcare call.

Following the conclusion of the conference call, a replay will be available through May 11, 2017, and can be accessed by dialing 1-877-344-7529 (U.S. Toll-Free), 1-412-317-0088 (International), and 1-855-669-9658 (Canada Toll-Free). All listeners should provide the replay passcode 10106354. The call will also be archived on the Company website for a time at https://www.sensushealthcare.com

About Sensus Healthcare

Sensus Healthcare, Inc. is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancers and keloids. Sensus uses a proprietary low energy X-ray radiation technology known as superficial radiation therapy (SRT), which is a result of over a decade of dedicated research and development activities. Sensus has successfully incorporated the SRT therapy into its portfolio of treatment devices, the SRT-100™ and SRT-100 Vision™. To date, the SRT technology has been used to effectively and safely treat oncological and non-oncological skin conditions in thousands of patients. For further information, please visit https://www.sensushealthcare.com

Contacts:

Investors
LHA
Kim Sutton Golodetz
(212) 838-3777
kgolodetz@lhai.com

SOURCE Sensus Healthcare

Share to:

Contact Us

Fill out the form below to find out more!